We found that the major factor of the tumor immunophenotype variation was characterized by a strong inverse relation between the expression of ER, PR, AR along with anti-apoptotic marker BCL2, on one side, and Ki67 and HIF-1α, on the other side. The gene discussed is MKI67; the disease is neoplasm.